The following is the latest list of selected news summaries by Kyodo News.----------Japan's Astellas to buy U.S. drugmaker Iveric Bio for $5.9 bil.TOKYO - Astellas Pharma Inc. said Monday it will buy U.S. pharmaceutical company Iveric Bio Inc. for about $5.9 billion in its largest takeover, as the Japanese drugmaker pushes ahead with its acquisition drive.Astellas will acquire all outstanding shares of Iveric Bio, which focuses on ophthalmology treatments, for $40 per share through its U.S. unit, Astellas US Holdings Inc., with the transaction expected to be completed by the end of Septembe…READ FULL ARTICLE